In vivo modeling of metastatic human high-grade serous ovarian cancer in mice.

TitleIn vivo modeling of metastatic human high-grade serous ovarian cancer in mice.
Publication TypeJournal Article
Year of Publication2020
AuthorsKim, O, Park, EYoung, Klinkebiel, DL, Pack, SD, Shin, Y-H, Abdullaev, Z, Emerson, RE, Coffey, DM, Kwon, SYoung, Creighton, CJ, Kwon, S, Chang, EC, Chiang, T, Yatsenko, AN, Chien, J, Cheon, D-J, Yang-Hartwich, Y, Nakshatri, H, Nephew, KP, Behringer, RR, Fernández, FM, Cho, C-H, Vanderhyden, B, Drapkin, R, Bast, RC, Miller, KD, Karpf, AR, Kim, J
JournalPLoS Genet
Volume16
Issue6
Paginatione1008808
Date Published2020 Jun
ISSN1553-7404
KeywordsAnimals, Antineoplastic Agents, Cell Line, Tumor, Chromosomal Instability, Cystadenocarcinoma, Serous, DEAD-box RNA Helicases, Disease Models, Animal, DNA Repair, Drug Resistance, Neoplasm, Drug Screening Assays, Antitumor, Feasibility Studies, Female, Humans, Mice, Mice, Knockout, Mutation, Neoplasm Grading, Neoplasm Metastasis, Ovarian Neoplasms, Peritoneal Neoplasms, Primary Cell Culture, PTEN Phosphohydrolase, Ribonuclease III, Tumor Suppressor Protein p53
Abstract

Metastasis is responsible for 90% of human cancer mortality, yet it remains a challenge to model human cancer metastasis in vivo. Here we describe mouse models of high-grade serous ovarian cancer, also known as high-grade serous carcinoma (HGSC), the most common and deadliest human ovarian cancer type. Mice genetically engineered to harbor Dicer1 and Pten inactivation and mutant p53 robustly replicate the peritoneal metastases of human HGSC with complete penetrance. Arising from the fallopian tube, tumors spread to the ovary and metastasize throughout the pelvic and peritoneal cavities, invariably inducing hemorrhagic ascites. Widespread and abundant peritoneal metastases ultimately cause mouse deaths (100%). Besides the phenotypic and histopathological similarities, mouse HGSCs also display marked chromosomal instability, impaired DNA repair, and chemosensitivity. Faithfully recapitulating the clinical metastases as well as molecular and genomic features of human HGSC, this murine model will be valuable for elucidating the mechanisms underlying the development and progression of metastatic ovarian cancer and also for evaluating potential therapies.

DOI10.1371/journal.pgen.1008808
Alternate JournalPLoS Genet
PubMed ID32497036
PubMed Central IDPMC7297383
Grant ListP50 CA217685 / CA / NCI NIH HHS / United States
R00 CA179137 / CA / NCI NIH HHS / United States
R01 CA218664 / CA / NCI NIH HHS / United States
UL1 TR001863 / TR / NCATS NIH HHS / United States

Similar Publications